Fundz

Iylon Appoints Mary Lopresti as Chief Medical Officer

PRIVATEAug 27, 2026

Position

Chief Medical Officer

Company

Iylon

Mary Lopresti, D.O.
ProvidenceBiotechnologyHealth CareMedicalTherapeutics

Description

Iylon has announced the appointment of Mary Lopresti, D.O., as Chief Medical Officer. Dr. Lopresti will enhance Iylon's precision oncology services by providing clinical leadership and guiding the company's medical data review process.

Quick answer

Iylon Appoints Mary Lopresti as Chief Medical Officer (August 27, 2026). Iylon is based in Providence, Rhode Island, United States.

What did Iylon announce on August 27, 2026?
Iylon has announced the appointment of Mary Lopresti, D.O., as Chief Medical Officer. Dr. Lopresti will enhance Iylon's precision oncology services by providing clinical leadership and guiding the company's medical data review process.
What does Iylon do?
Iylon is a precision oncology company dedicated to helping physicians and their patients navigate complex cancer-treatment options.
Where is Iylon based?
Iylon is based in Providence, Rhode Island, United States.
Which similar companies made leadership changes around the same time?
NYU Langone Health (August 27, 2026), Acrivon Therapeutics (August 31, 2026), Abivax (September 7, 2026) and Novocure (September 9, 2026) also announced leadership changes within 45 days of Iylon.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Iylon, and when

A new leader at Iylon brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Iylon raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Iylon, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Iylon. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Iylon

Location

Providence, Rhode Island, United States

About

Iylon is a precision oncology company dedicated to helping physicians and their patients navigate complex cancer-treatment options. Founded in 2020, it integrates clinical oncology expertise with molecular and scientific insight to provide personalized reviews of individual cancer cases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Iylon changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Arun
Likely contact at this company
••••••••@••••••••

See Arun's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Iylon's next move

Learn about Strategic plan

Iylon changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.